ホーム › 潰瘍性大腸炎 › フロリダ州 › Orlando
Orlando、FLにおける潰瘍性大腸炎の臨床試験
Orlandoとその周辺地域（約30マイル以内）の拠点で、潰瘍性大腸炎に関する22件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
被験者募集中第2相
- Digestive And Liver Center Of Florida - Orlando /ID# 280924, Orlando
- Clinical Research of Osceola /ID# 280593, Kissimmee · 16マイル先
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
被験者募集中第4相
- Endoscopic Research, Inc., Orlando
- Orlando Health-Orlando Regional Medical Center, Orlando
- Digestive and Liver Center of Florida, P.A., Kissimmee · 16マイル先
Confirmatory Clinical Study in Active Ulcerative Colitis
被験者募集中第2相
- Orlando Gastroenterology, P.A., Orlando
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
被験者募集中第2相
- Orlando Health Digestive Health Institute, Orlando
- AdventHealth Orlando, Orlando
- Novum Research, LLC, Clermont · 24マイル先
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
被験者募集中第1/2相健康なボランティア歓迎
- Xencor Investigative Site, Kissimmee · 16マイル先
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
被験者募集中第2相
- Site 007, Kissimmee · 16マイル先
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
被験者募集中第2相
- Site US-026, Orlando
A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
被験者募集中第2相
- AdventHealth Orlando ( Site 1074), Orlando
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
被験者募集中第2相
- Clinical Research of Osceola, LLC, Kissimmee · 16マイル先
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
被験者募集中第3相
- Orlando Health, Orlando
- Digestive and Liver Center of Florida, Orlando
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
被験者募集中第2相
- Digestive and Liver Center of Florida, Orlando
- Clinical Research of Osceola, Kissimmee · 16マイル先
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
被験者募集中第2相
- AdventHealth Orlando, Orlando
- Clinical Research of Osceola, Kissimmee · 16マイル先
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
被験者募集中第4相
- Endoscopic Research Inc, Orlando
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
被験者募集中第3相
- Clinical Research of Osceola - Site Number: 8400013, Kissimmee · 16マイル先
A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
被験者募集中第2相
- Primary Care of Osceola, Kissimmee · 16マイル先
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
被験者募集中第3相
- Orlando Health, Inc. - Site Number: 8400084, Orlando
- AdventHealth Orlando - Site Number: 8400070, Orlando
- Clinical Research of Osceola - Site Number: 8400013, Kissimmee · 16マイル先
- 他1件
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
被験者募集中
- Advent Health, Orlando
Zymfentra (Infliximab-dyyb) REal World Cohort STudy
被験者募集中観察研究
- AdventHealth, Orlando
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
被験者募集中観察研究
- Orlando Health/Digestive Health Institute, Orlando
- Digestive and Liver Center of Florida Kissimmee, Kissimmee · 16マイル先
A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
被験者募集中第2相
- Arnold Palmer Hospital - Center for Digestive Health and Nutrition, Orlando
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
被験者募集中第2相
- Mirador Therapeutics Selected Site, Orlando
Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)
被験者募集中
- Orlando Health, Orlando
他の都市における潰瘍性大腸炎の試験
- New York City, NY23件の研究
- Miami, FL21件の研究
- Houston, TX17件の研究
- San Antonio, TX16件の研究
- Chicago, IL15件の研究
- Tacoma, WA15件の研究
- San Diego, CA15件の研究
- Tyler, TX14件の研究
- Colorado Springs, CO14件の研究
- Los Angeles, CA13件の研究
- St. Louis, MO13件の研究
- Washington, DC12件の研究
Orlandoにおける他の研究
- 非小細胞肺癌44件の研究
- 肥満症31件の研究
- 転移性癌29件の研究
- 過体重27件の研究
- アルツハイマー病25件の研究
- 2型糖尿病24件の研究
- がん（全種類）24件の研究
- 乳がん23件の研究
- 卵巣がん22件の研究
- 肺がん21件の研究
- 大腸癌19件の研究
- 大うつ病性障害19件の研究
ClinicalTrials.govより、2026/10/04時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。